Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Long-hui Cao
Quantitative Assessment of Tumor Blood Flow in Mice After Treatment With Different Doses of an Antiangiogenic Agent With Contrast-Enhanced Destruction-Replenishment US
Radiology
Nuclear Medicine
Radiology
Imaging
Dose-Response Relationship in Cisplatin-Treated Breast Cancer Xenografts Monitored With Dynamic Contrast-Enhanced Ultrasound
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Prostate Cancer Ablation With Transrectal High-Intensity Focused Ultrasound: Assessment of Tissue Destruction With Contrast-Enhanced US
Radiology
Nuclear Medicine
Radiology
Imaging
Complete Bubble Destruction Is Essential for Quantitative Assessment From the Replenishment Curve in Real-Time Myocardial Contrast Echocardiography
Journal of Echocardiography
Nuclear Medicine
Radiology
Imaging
Correlation of Ultrasound Contrast Agent Derived Blood Flow Parameters With Immunohistochemical Angiogenesis Markers in Murine Xenograft Tumor Models
Ultrasonics
Acoustics
Ultrasonics
Contrast-Enhanced Ultrasonography With Quantitative Analysis Allows Differentiation of Renal Tumor Histotypes
Scientific Reports
Multidisciplinary
Intraoperative Laser Speckle Contrast Imaging With Retrospective Motion Correction for Quantitative Assessment of Cerebral Blood Flow
Neurophotonics
Nuclear Medicine
Radiology
Ultrasound Technology
Radiological
Imaging
Neuroscience
Liver Dysplasia: US Molecular Imaging With Targeted Contrast Agent Enables Early Assessment
Radiology
Nuclear Medicine
Radiology
Imaging
Tumor Characterization With Dynamic Contrast Enhanced Magnetic Resonance Imaging and Biodegradable Macromolecular Contrast Agents in Mice
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Deeply Penetrating Photoacoustic Tomography in Biological Tissues Enhanced With an Optical Contrast Agent
Optics Letters
Optics
Atomic
Molecular Physics,
Preclinical Evaluation of Tumor Microvascular Response to a Novel Antiangiogenic/Antitumor Agent RO0281501 by Dynamic Contrast-Enhanced MRI at 1.5 T
Molecular Cancer Therapeutics
Cancer Research
Oncology
